Home NDC 66336-214 ISENTRESS
Product NDC 66336-214
11-digit product format 663360214
Labeler code 66336
Product ID 66336-214_cf313cc0-44c0-4f55-a021-8fab00af41ca
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name RALTEGRAVIR
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Dispensing Solutions, Inc.
Application NDA022145
Marketing category NDA
Marketing start 2007-10-12
Marketing end 0000-00-00
Substance RALTEGRAVIR POTASSIUM
Active strength 400 mg/1
Pharmacologic classes HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 66336-214-06 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 66336-214-06 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 66336-214-06 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 66336-214-06 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 66336-214-06 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 66336-214-06 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 66336-214-06 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 66336-214-06 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 66336-214-06 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 66336-214-06 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 66336-214-06 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 66336-214-06 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 66336-214-06 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 66336-214-06 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 66336-214-06 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 66336-214-06 fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 66336-214-06 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 66336-214-06 bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 66336-214-06 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 66336-214-06 e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 66336-214-06 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 66336-214-06 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022145-001 ISENTRESS RALTEGRAVIR POTASSIUM EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 N022145-002 ISENTRESS HD RALTEGRAVIR POTASSIUM EQ 600MG BASE TABLET / ORAL AB RLD, RS 2017-05-26
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N022145-002 AB
Orange Book patents# Current patent rows page 1 of 1 · 10 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N022145-001 8852632 2028-01-28 U-257 Drug substance, Drug product 2023-03-27 N022145-001 7754731 2029-03-11 U-257 Drug substance, Drug product N022145-001 7754731*PED 2029-09-11 Pediatric extension N022145-001 8771733 2030-06-02 U-257 Drug substance, Drug product 2023-03-27 N022145-002 7754731 2029-03-11 U-257 Drug substance, Drug product 2017-06-23 N022145-002 7754731*PED 2029-09-11 Pediatric extension N022145-002 8771733 2030-06-02 U-257 Drug substance, Drug product 2023-03-27 N022145-002 9649311 2030-10-21 Drug product 2017-06-23 N022145-002 9649311*PED 2031-04-21 Pediatric extension N022145-002 10772888 2032-03-30 U-1663 2020-10-27
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL AB RLD, RS 2017-05-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL AB RLD, RS 2017-05-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL AB RLD, RS 2017-05-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL RLD, RS 2017-05-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL RLD, RS 2017-05-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL AB RLD, RS 2007-10-12 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL RLD, RS 2017-05-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL RLD, RS 2017-05-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL RLD, RS 2017-05-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL RLD, RS 2017-05-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL RLD, RS 2017-05-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL RLD, RS 2017-05-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL RLD, RS 2017-05-26 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL RLD, RS 2017-05-26 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL RLD, RS 2017-05-26 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL RLD, RS 2017-05-26 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL RLD, RS 2017-05-26 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL RLD, RS 2017-05-26 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL RLD, RS 2017-05-26 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL RLD, RS 2017-05-26 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022145-001 ISENTRESS EQ 400MG BASE TABLET / ORAL RLD, RS 2007-10-12 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N022145-002 ISENTRESS HD EQ 600MG BASE TABLET / ORAL RLD, RS 2017-05-26 782e0a99824c…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 17 · 674 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N022145-001 8852632 2028-01-28 U-257 Drug substance, Drug product 2023-03-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022145-001 7754731 2029-03-11 U-257 Drug substance, Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022145-001 7754731*PED 2029-09-11 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022145-001 8771733 2030-06-02 U-257 Drug substance, Drug product 2023-03-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022145-002 7754731 2029-03-11 U-257 Drug substance, Drug product 2017-06-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022145-002 7754731*PED 2029-09-11 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022145-002 8771733 2030-06-02 U-257 Drug substance, Drug product 2023-03-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022145-002 9649311 2030-10-21 Drug product 2017-06-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022145-002 9649311*PED 2031-04-21 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022145-002 10772888 2032-03-30 U-1663 2020-10-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022145-001 8852632 2028-01-28 U-257 Drug substance, Drug product 2023-03-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022145-001 7754731 2029-03-11 U-257 Drug substance, Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022145-001 7754731*PED 2029-09-11 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022145-001 8771733 2030-06-02 U-257 Drug substance, Drug product 2023-03-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022145-002 7754731 2029-03-11 U-257 Drug substance, Drug product 2017-06-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022145-002 7754731*PED 2029-09-11 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022145-002 8771733 2030-06-02 U-257 Drug substance, Drug product 2023-03-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022145-002 9649311 2030-10-21 Drug product 2017-06-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022145-002 9649311*PED 2031-04-21 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022145-002 10772888 2032-03-30 U-1663 2020-10-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022145-001 8852632 2028-01-28 U-257 Drug substance, Drug product 2023-03-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022145-001 7754731 2029-03-11 U-257 Drug substance, Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022145-001 7754731*PED 2029-09-11 Pediatric extension 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022145-001 8771733 2030-06-02 U-257 Drug substance, Drug product 2023-03-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022145-002 7754731 2029-03-11 U-257 Drug substance, Drug product 2017-06-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022145-002 7754731*PED 2029-09-11 Pediatric extension 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022145-002 8771733 2030-06-02 U-257 Drug substance, Drug product 2023-03-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022145-002 9649311 2030-10-21 Drug product 2017-06-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022145-002 9649311*PED 2031-04-21 Pediatric extension 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022145-002 10772888 2032-03-30 U-1663 2020-10-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022145-001 8852632 2028-01-28 U-257 Drug substance, Drug product 2023-03-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022145-001 7754731 2029-03-11 U-257 Drug substance, Drug product fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022145-001 7754731*PED 2029-09-11 Pediatric extension fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022145-001 8771733 2030-06-02 U-257 Drug substance, Drug product 2023-03-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022145-002 7754731 2029-03-11 U-257 Drug substance, Drug product 2017-06-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022145-002 7754731*PED 2029-09-11 Pediatric extension fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022145-002 8771733 2030-06-02 U-257 Drug substance, Drug product 2023-03-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022145-002 9649311 2030-10-21 Drug product 2017-06-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022145-002 9649311*PED 2031-04-21 Pediatric extension fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022145-002 10772888 2032-03-30 U-1663 2020-10-27 fd3edfee7708…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 54 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 66336-214-06 ISENTRESS 6 in 1 BOTTLE TABLET, FILM COATED 6 2
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded RALTEGRAVIR POTASSIUM ACTIVE INGREDIENT 43Y000U234 ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.] 2 RALTEGRAVIR ACTIVE MOIETY 22VKV8053U ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.] 2 BUTYLATED HYDROXYTOLUENE INACTIVE INGREDIENT 1P9D0Z171K ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.] 2 CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS INACTIVE INGREDIENT L11K75P92J ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.] 2 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.] 2 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.] 2 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.] 2 POLOXAMER 407 INACTIVE INGREDIENT TUF2IVW3M2 ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.] 2 POLYETHYLENE GLYCOL 3350 INACTIVE INGREDIENT G2M7P15E5P ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.] 2 POLYVINYL ALCOHOL INACTIVE INGREDIENT 532B59J990 ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.] 2 SODIUM STEARYL FUMARATE INACTIVE INGREDIENT 7CV7WJK4UI ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.] 2 TALC INACTIVE INGREDIENT 7SEV7J4R1U ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 66336-214 ISENTRESS (RALTEGRAVIR) TABLET, FILM COATED [DISPENSING SOLUTIONS, INC.] 2 Legacy NDC, 1 package rows 20130625_b05735be-d278-4c31-bfb5-ebf74ce42b89.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 66336-214-06 66336021406 6 in 1 BOTTLE Historical